Company intelligence / Profile preview

KX (formerly KX Systems)

New York, New York, United States

Ownership: Private
Employees: ~544
Development stage: Other

Overview

KX provides ultra-fast data analytics software used chiefly in capital markets, but increasingly by sectors such as healthcare and life sciences for high-frequency, high-volume data challenges. No direct clinical results, but platforms are deployed for digital transformation projects in pharma R&D, AI, and analytics.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

NVIDIAMicrosoftAWS (Amazon Web Services)Lockheed MartinJP MorganMorgan StanleyUBSRxDataScience (invested/startup partner for AI/analytics in pharma)

Beyond the preview

Go deeper on KX (formerly KX Systems).

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KX (formerly KX Systems).

Explore the full profile